Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
J Clin Gastroenterol. 2011 Sep;45(8):727-32. doi: 10.1097/MCG.0b013e31820989d3.
Surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosis, but earlier studies suggest that it is used less than one-third of the time. Patient factors associated with surveillance rates are incompletely understood.
The aims of our study were to determine HCC surveillance rates in a tertiary-care center and to identify patient predictors of receiving surveillance.
Patients with Child A or B cirrhosis seen in the University of Michigan liver clinics between October 2008 and March 2009 were enrolled to complete a self-administered survey. Surveillance rates and clinical data were extracted from the patient electronic medical record.
Of the 160 patients enrolled, 74.4% had HCC surveillance performed in the past year. On multivariate analysis, predictors of receiving surveillance included male sex (odds ratio 7.1, 95% confidence interval, 1.2-43.2) and patient involvement in their care (odds ratio 3.4, 95% confidence interval, 1.5-7.9). Patients expressed high levels of concern regarding HCC, desired more information from their physicians, and wanted to be more involved in their care.
HCC surveillance rates in a tertiary-care center were significantly higher than earlier reported rates. Direct patient involvement in decisions regarding HCC surveillance may help to improve surveillance rates.
在肝硬化患者中推荐进行肝细胞癌(HCC)监测,但早期研究表明,监测的实施率不足三分之一。与监测率相关的患者因素尚不完全清楚。
我们研究的目的是确定在三级保健中心 HCC 监测率,并确定接受监测的患者预测因素。
2008 年 10 月至 2009 年 3 月在密歇根大学肝脏诊所就诊的 Child A 或 B 级肝硬化患者入组完成自我管理调查。从患者电子病历中提取监测率和临床数据。
在 160 名入组患者中,74.4%的患者在过去一年中进行了 HCC 监测。多变量分析显示,接受监测的预测因素包括男性(比值比 7.1,95%置信区间,1.2-43.2)和患者对其治疗的参与(比值比 3.4,95%置信区间,1.5-7.9)。患者对 HCC 有很高的担忧程度,希望从医生那里获得更多的信息,并希望更积极地参与自己的治疗。
在三级保健中心 HCC 监测率明显高于早期报告的监测率。直接让患者参与 HCC 监测决策可能有助于提高监测率。